Access to HIV/AIDS Medicines in Exchanges (2014)

Access to HIV/AIDS Medicines in Exchanges

Prescription medicines are a crucial component of treatment for HIV/AIDS. Multidrug regimens have substantially reduced HIV progression to AIDS, opportunistic infections, hospitalizations, and deaths. Even so, early ART regimens often required patients to ingest several large pills multiple times per day. New formulations, such as single-tablet regimens, reduced the pill burden dramatically, improving adherence and slowing disease progression. This fact sheet offers insight into access to these medicines in the new health insurance exchanges. Key findings are primarily based on an analysis of 84 plans in the 15 states with the highest expected exchange enrollment for 2014.

View the Fact Sheet

More On PhRMA — powered by PhRMApedia


Cost in Context